University of Manchester scientists working on an app for psychosis therapy receive government funding.

Scientists developing an app which provides cognitive behavioural therapy (CBT) to first time sufferers of psychotic episodes have received a £450k ($680k) injection from the Medical Research Council (MRC).

The funding comes after the UK Government announced the third wave of its Biomedical Catalyst scheme, a £25.9m chunk of an overall package of £93m designed to stimulate UK life science firms.

Dr Bucci, lead investigator of the study from the University of Manchester, said: “Schizophrenia is a serious mental…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?